What does CUSIP 61023L108 represent in this 13F holders report?

CUSIP 61023L108 is the security identifier for MNPR - MONOPAR THERAPEUTICS INC - COM used to aggregate holder disclosures.

How many institutions held MNPR - MONOPAR THERAPEUTICS INC - COM in Q1 2021?

12 institutional investors reported MNPR - MONOPAR THERAPEUTICS INC - COM for Q1 2021. Use the holders table for investor-level position and value details.

MONOPAR THERAPEUTICS INC - COM (MNPR)

CUSIP: 61023L108

Q1 2021 13F Holders as of 31 Mar 2021

Security type / class: Equity / COM
Total 13F shares: 194,795
Total 13F value: $1,207,340
Share change: +124,885
SEC-reported price per share: $6.20
Number of holders: 12
Value change: +$772,998
Number of buys: 8
Number of sells: 2

Security key

61023L108

Report period

Q1 2021

Institutions

Top holders

MNPR full security history Ownership snapshot Full 13F holder table Monopar Therapeutics SEC filings Monopar Therapeutics company facts Monopar Therapeutics 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of MNPR - MONOPAR THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

NORTHERN TRUST CORP

Disclosed value leader

NORTHERN TRUST CORP

Comparable rows

0/6

Latest evidence

31 Dec 2020

13F Highest disclosed value: $360,000 6 rows are not safely comparable across share classes.

Quick read

NORTHERN TRUST CORP has the largest disclosed position value at $360K.

0 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens NORTHERN TRUST CORP's linked filing trail.

Disclosed position value Top 5

NORTHERN TRUST CORP $360K

BlackRock Finance, Inc. $33K

MORGAN STANLEY $20K

Tower Research Capital LLC (TRC) $9K

UBS Group AG $6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 6 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
NORTHERN TRUST CORP	13F Company 13F	— denominator unverified	$360,000 58,793 shares	—	31 Dec 2020
BlackRock Finance, Inc.	13F Company 13F	— denominator unverified	$33,000 5,391 shares	—	31 Dec 2020
MORGAN STANLEY	13F Company 13F	— denominator unverified	$20,000 3,200 shares	—	31 Dec 2020
Tower Research Capital LLC (TRC)	13F Company 13F	— denominator unverified	$9,000 1,404 shares	—	31 Dec 2020
UBS Group AG	13F Company 13F	— denominator unverified	$6,000 952 shares	—	31 Dec 2020
CAPTRUST FINANCIAL ADVISORS	13F Company 13F	— denominator unverified	$1,000 170 shares	—	31 Dec 2020

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

194,795

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Holder diff

Investor	Q1 2021 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q1 2021 value	Q1 2021 value	Value change	Value Chg %